A call to caution when hydroxychloroquine is given to elderly patients with COVID-19

A call to caution when hydroxychloroquine is given to elderly patients with COVID-19

Introduction: Use of hydroxychloroquine in patients with coronavirus disease 2019 (COVID-19) was widespread and uncontrolled until recently. Patients vulnerable to severe COVID-19 are at risk of hydroxychloroquine interactions with co-morbidities and co-medications contributing to detrimental, inclu...

Full description

Bibliographic Details
Main Authors: Julian J. Gabor, Andrea Kreidenweiss, Stefan Weber, Moaaz Salama, Mihaly Sulyok, Zita Sulyok, Erik Koehne, Meral Esen, Benno Kreuels, Parichehr Shamsrizi, Erwin Biecker, Benjamin Mordmüller, Christoph P. Berg, Stefano Fusco, Carsten Köhler, Stefan Kubicka, Jens Leitlein, Marylyn Addo, Michael Ramharter, Matthias Schwab, Alfred Lennart Bissinger, Thirumalaisamy P. Velavan, Sanjeev Krishna, Peter G. Kremsner
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Hydroxychloroquine
Contraindications
Adverse effects
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221003209

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221003209

Similar Items